1-4 of 4
G K Schwartz
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

UCN-01 suppresses thymidylate synthase gene expression and enhances 5-fluorouracil-induced apoptosis in a sequence-dependent manner.

Free
C T Hsueh, D Kelsen, G K Schwartz
Journal: Clinical Cancer Research
Clin Cancer Res (1998) 4 (9): 2201–2206.
Published: 01 September 1998
View articletitled, UCN-01 suppresses thymidylate synthase gene expression and enhances 5-fluorouracil-induced apoptosis in a sequence-dependent manner.
Open the PDF for UCN-01 suppresses thymidylate synthase gene expression and enhances 5-fluorouracil-induced apoptosis in a sequence-dependent manner. in another window
Journal Articles

UCN-01 in ovary cancer cells: effective as a single agent and in combination with cis-diamminedichloroplatinum(II)independent of p53 status.

Free
A Husain, X J Yan, N Rosales, C Aghajanian, G K Schwartz, D R Spriggs
Journal: Clinical Cancer Research
Clin Cancer Res (1997) 3 (11): 2089–2097.
Published: 01 November 1997
View articletitled, UCN-01 in ovary cancer cells: effective as a single agent and in combination with cis-diamminedichloroplatinum(II)independent of p53 status.
Open the PDF for UCN-01 in ovary cancer cells: effective as a single agent and in combination with cis-diamminedichloroplatinum(II)independent of p53 status. in another window
Journal Articles

Potentiation of apoptosis by flavopiridol in mitomycin-C-treated gastric and breast cancer cells.

Free
G K Schwartz, K Farsi, P Maslak, D P Kelsen, D Spriggs
Journal: Clinical Cancer Research
Clin Cancer Res (1997) 3 (9): 1467–1472.
Published: 01 September 1997
View articletitled, Potentiation of apoptosis by flavopiridol in mitomycin-C-treated gastric and breast cancer cells.
Open the PDF for Potentiation of apoptosis by flavopiridol in mitomycin-C-treated gastric and breast cancer cells. in another window
Journal Articles

A pilot clinical/pharmacological study of the protein kinase C-specific inhibitor safingol alone and in combination with doxorubicin.

Free
G K Schwartz, D Ward, L Saltz, E S Casper, T Spiess, E Mullen, J Woodworth, R Venuti, P Zervos, A M Storniolo, D P Kelsen
Journal: Clinical Cancer Research
Clin Cancer Res (1997) 3 (4): 537–543.
Published: 01 April 1997
View articletitled, A pilot clinical/pharmacological study of the protein kinase C-specific inhibitor safingol alone and in combination with doxorubicin.
Open the PDF for A pilot clinical/pharmacological study of the protein kinase C-specific inhibitor safingol alone and in combination with doxorubicin. in another window